|Day's Range||13.44 - 13.82|
|52 Week Range||8.31 - 32.74|
|PE Ratio (TTM)||-3.32|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
Billionaires appear to have focused on drug stocks that were mired in debt in Q1.
Eyegate Pharmaceuticals Inc. stock surged 11% in premarket trade Monday after the company said it had received its first milestone payment from Valeant Pharmaceuticals International Inc. resulting from ...
Feeling brave? These value stocks could provide incredible returns to investors willing to take on the risk.